The rate at which people are dying of opioid overdoses in America is accelerating. Medication-assisted treatment (MAT) alongside harm-reduction measures such as needle exchanges and supervised injection facilities have proven successful in other countries, but have failed to gain support in the U.S. We set up a Creative Focus test to determine where popular support currently stands on MAT and needle exchanges, and which messages impact support levels.